Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 1/20 | 0.67 |
| ▸ | CCR5 | P51681 | 1/20 | 0.67 |
| ▸ | CCR8 | P51685 | 1/20 | 0.67 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.61 |
| ▸ | UHRF1 | Q96T88 | 1/20 | 0.48 |
| ▸ | METAP2 | P50579 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.45 |
| ▸ | MEN1 | O00255 | 3/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | NOS3 | P29474 | 1/20 | 0.45 |
| ▸ | NOS1 | P29475 | 1/20 | 0.45 |
| ▸ | NOS2 | P35228 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | FLT3 | P36888 | 1/20 | 0.43 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19020245 | 0.90 | CCR1 (0.59) | CCR1CCR5CCR8CYP2A6UHRF1 | |
| SCHEMBL27344644 | 0.89 | CCR1 (0.76) | CCR1CCR5CCR8CYP2A6UHRF1 | |
| SCHEMBL31695263 | 0.89 | CCR1 (0.76) | CCR1CCR5CCR8CYP2A6UHRF1 | |
| SCHEMBL6807225 | 0.84 | CCR1 (0.70) | CCR1CCR5CCR8CYP2A6UHRF1 | |
| SCHEMBL29463685 | 0.84 | CCR1 (0.70) | CCR1CCR5CCR8CYP2A6UHRF1 | |
| SCHEMBL19009240 | 0.84 | CYP2A6 (0.58) | CCR1CCR5CCR8CYP2A6KDM4E | |
| SCHEMBL29446990 | 0.83 | CYP2A6 (0.67) | CCR1CCR5CCR8CYP2A6UHRF1 | |
| SCHEMBL842170 | 0.83 | CYP2A6 (0.67) | CCR1CCR5CCR8CYP2A6UHRF1 | |
| SCHEMBL12339160 | 0.82 | NPC1 (0.50) | CCR1CCR5CCR8CYP2A6KDM4E | |
| SCHEMBL12339139 | 0.82 | NPC1 (0.50) | CCR1CCR5CCR8CYP2A6KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 138 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11818932-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-11-14 | — | — | US | disclosed |
| US-11706973-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-07-18 | — | — | US | disclosed |
| US-11696496-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-07-04 | — | — | US | disclosed |
| US-11678498-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-06-13 | — | — | US | disclosed |
| US-11653563-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-05-16 | — | — | US | disclosed |
| US-20230096132-A1 | CYCLOALKANE-FUSED POLYCYCLIC AROMATIC COMPOUND | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2023-03-30 | — | — | US | disclosed |
| US-11617290-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-03-28 | — | — | US | disclosed |
| US-11329230-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-05-10 | — | — | US | disclosed |
| US-11316117-B2 | Organometallic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-04-26 | — | — | US | disclosed |
| US-20210336144-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-10-28 | — | — | US | disclosed |
| US-20110112077-A1 | Quinolizidinone m1 Receptor Positive Allosteric Modulators | MERCK SHARP & DOHME CORP. (US) | 2011-05-12 | — | — | US | disclosed |
| US-20100249406-A1 | PHENYL-SUBSTITUTED 1,3.5-TRIAZINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND ORGANIC ELECTROLUMINESCENT DEVICE CONTAINING THE SAME AS COMPONENT | TOSOH CORPORATION (JP) | 2010-09-30 | — | — | US | disclosed |
| US-20100249406-A1 | PHENYL-SUBSTITUTED 1,3.5-TRIAZINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND ORGANIC ELECTROLUMINESCENT DEVICE CONTAINING THE SAME AS COMPONENT | TOSOH CORPORATION (JP) | 2010-09-30 | — | — | US | disclosed |
| US-20100204235-A1 | ORGANIC COMPOUNDS | NOVARTIS AG (CH) | 2010-08-12 | — | — | US | disclosed |
| US-20100204235-A1 | ORGANIC COMPOUNDS | NOVARTIS AG (CH) | 2010-08-12 | — | — | US | disclosed |
| US-20100041662-A1 | Heterocyclic compounds as antiinflammatory agents | FERRAND SANDRINE | 2010-02-18 | — | — | US | disclosed |
| US-20100041662-A1 | Heterocyclic compounds as antiinflammatory agents | FERRAND SANDRINE | 2010-02-18 | — | — | US | disclosed |
| WO-2009013335-A1 | ORGANIC COMPOUNDS | NOVARTIS AG (CH) | 2009-01-29 | — | — | WO | disclosed |
| WO-2008052734-A1 | HETEROCYCLIC COMPOUNDS AS ANTIINFLAMMATORY AGENTS | NOVARTIS AG (CH) | 2008-05-08 | — | — | WO | disclosed |
| WO-2002076983-A1 | IMIDAZO-PYRIMIDINE DERIVATIVES AS LIGANDS FOR GABA RECEPTORS | MERCK SHARP & DOHME LIMITED (GB) | 2002-10-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230096132-A1 | CYCLOALKANE-FUSED POLYCYCLIC AROMATIC COMPOUND | LAGE3, ELOC, ELOB | CCR1 275/4885CCR5 1093/4885CCR8 53/4885 |
| US-11329230-B2 | Organic light-emitting device | EML4, SUN2, TRPA1 | CCR1 2925/4885CCR5 2650/4885CCR8 2616/4885 |
| US-11706973-B2 | Condensed cyclic compound and organic light-emitting device including the same | C1S, CCNT1, C9 | CCR1 72/4885CCR5 894/4885CCR8 874/4885 |
| US-20100204235-A1 | ORGANIC COMPOUNDS | ALK, OR10J3, FFAR4 | CCR1 368/4885CCR5 247/4885CCR8 523/4885 |
| US-20100249406-A1 | PHENYL-SUBSTITUTED 1,3.5-TRIAZINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND ORGANIC ELECTROLUMINESCENT DEVICE CONTAINING THE SAME AS COMPONENT | H1-5, H1-4, H1-2 | CCR1 2985/4885CCR5 3911/4885CCR8 4529/4885 |
| US-11316117-B2 | Organometallic compound and organic light-emitting device including the same | OCIAD1, L3MBTL1, OCIAD2 | CCR1 1787/4885CCR5 2620/4885CCR8 4025/4885 |
| US-20100041662-A1 | Heterocyclic compounds as antiinflammatory agents | JAK2, IRAK4, ALK | CCR1 223/4885CCR5 191/4885CCR8 321/4885 |
| US-20110112077-A1 | Quinolizidinone m1 Receptor Positive Allosteric Modulators | CHRM1, CHRM2, OPRL1 | CCR1 3490/4885CCR5 1469/4885CCR8 4805/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.